Clinical Trial Update: Pembrolizumab and GM-CSF in Biliary Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pembrolizumab in combination with GM-CSF for biliary cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cancer

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Robin Kate Kelley | Conditions: Biliary Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-01-12